Dr. Silke Gillessen is joined by Drs. Thomas Zilli (specializing in radiation oncology), Jochen Walz (urology) and Ken Hermann (nuclear medicine) to discuss the top highlights from 2024 in the prostate cancer field from each of their unique perspectives.